Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Agency for Healthcare Research and Quality (AHRQ) | FED |
| Vanderbilt University | OTHER |
| Stanford University | OTHER |
Not provided
Not provided
Not provided
Not provided
Intermountain Health has developed a electronic decision support tool to help doctors provide the best care for pneumonia. The purpose of this study is to enhance the existing tool (called ePneumonia (electronic Pneumonia) or ePNa) so that it can be used at other institutions, and to test deployment of the tool at another institution's hospitals.
This study as funded by the AHRQ (Agency for Healthcare Research and Quality) involves making the current ePNa system a "SMART on FHIR" compatible application that will enable the same core software and processes to work across the Cerner and Epic electronic health record platforms. The investigators will then engage with emergency department providers and patients to improve user centered design, considering clinician preferences and feedback for use as well as patient needs for information. Finally, the investigators will evaluate the feasibility and acceptability via a pilot implementation trial of the interoperable ePNa platform at two Vanderbilt affiliated hospitals.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Implementation at Vanderbilt University Medical Center (VUMC) & Vanderbilt Wilson County Hospital | Experimental | ePNa (the decision support tool) will be implemented at 2 EDs that are part of the Vanderbilt Health system. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ePNa | Other | Real-time, automated clinical decision support tool for pneumonia (called "ePNa") |
|
| Measure | Description | Time Frame |
|---|---|---|
| 14-day hospital-free days | 14-day hospital-free days (a metric which captures outpatient disposition from the emergency department, secondary hospital admission, and length of stay) | 14 days after initial presentation to the emergency department |
| Measure | Description | Time Frame |
|---|---|---|
| 30-day all-cause mortality | At 30 days after initial ED presentation | |
| ED length of stay (hours) | At ED discharge | |
| ICU length of stay (days) |
Not provided
Inclusion Criteria:
For the baseline database and assessment of clinical outcomes, all data will be pulled from the Epic Clarity data warehouse.
Exclusion Criteria:
For all above patients:
For the groups selected by ICD-10 pneumonia codes, an additional exclusion is:
• Patients without radiographic evidence of pneumonia or with clear radiographic evidence for an alternative diagnosis.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Valerie Aston, MBA | Contact | 801-507-4606 | Valerie.Aston@imail.org | |
| David Tomer, MS | Contact | 801-507-4694 | David.Tomer@imail.org |
| Name | Affiliation | Role |
|---|---|---|
| Nathan Dean, MD | Intermountain Health | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011014 | Pneumonia |
| ID | Term |
|---|---|
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| At ICU discharge |
| Number of patients admitted to floor who are subsequently transferred to ICU within 72 hours | At 72 hours after inpatient admission |
| Time from ED presentation to first antibiotic dose (minutes) | At time of first antibiotic dose |